Unexplained weight loss (UWL), a decrease in body weight without an explicit effort to lose weight, is a common yet perplexing clinical scenario. It can be an indication of a variety of underlying conditions, ranging from benign to serious. This article aims to provide clinicians with a comprehensive approach to evaluating UWL in clinical practice.
The initial evaluation of UWL should focus on a thorough history and physical examination. The clinician should seek information about the duration, magnitude, and circumstances of the weight loss. Additionally, a detailed review of systems, focusing on symptoms that might suggest a specific etiology, is crucial.
After the initial assessment, the next step is to stratify patients based on their risk of having a serious underlying condition. This can be achieved by considering factors such as age, comorbidities, and the presence of alarming symptoms. Depending on the risk stratification, the approach to diagnostic testing may vary. For low-risk patients, a watchful waiting approach might be appropriate, whereas high-risk patients may require a more aggressive diagnostic work-up.
Imaging and laboratory tests play a vital role in the diagnostic work-up of UWL. The choice of tests should be guided by the clinical suspicion based on the history and physical examination. Commonly used tests include complete blood count, metabolic panel, thyroid function tests, and tumor markers. Imaging modalities such as computed tomography (CT) and positron emission tomography (PET) can also be useful, particularly in patients with a high suspicion of malignancy.
In conclusion, the evaluation of UWL is a complex process that requires a systematic approach. A thorough history and physical examination form the cornerstone of the evaluation, complemented by risk stratification and guided diagnostic testing. By applying this comprehensive approach, clinicians can efficiently identify the underlying cause of UWL and initiate appropriate management.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation